Insulin resistance and beta-cell failure begin long before a diagnosis of prediabetes and aggressive treatment should begin as early as possible to reduce risk for a variety of complications, according to a speaker.
“Pre-prediabetes is a new term to emphasize that diabetes, as well as its complications including cardiovascular disease, starts long before the prediabetic stage defined by the American Diabetes Association of an HbA1c between 5.7% and 6.4%,” Ralph A. DeFronzo, MD, professor of medicine and chief of the diabetes division at the University of Texas Health Science Center at San Antonio, told Healio. “Treatment to prevent diabetes and its associated accelerated CVD needs to be initiated at the pre-prediabetic/prediabetic stage.”
The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).